Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, Ray Blanco’s FDA Trader, Penny Pot Profits, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.
Opportunities can abound in a time of crisis for problem solvers, and solutions can come from unexpected quarters. Several of your biotech plays are potentially lucrative with a chance at reaching treatment for COVID-19. Just as well, other tech names are stepping up to the plate in different ways.
COVID-19 has forced over a billion people to stay at home globally. And state governments in the U.S. have deemed only essential businesses stay open. Businesses like utilities, grocery stores and… cannabis dispensaries?
We’ve seen short attacks on cannabis companies. They’re easy pickings for short-and-distort frauds. It’s easy to throw mud at companies, especially when making claims that involve technical accounting scams that most investors simply don’t understand. I’ve seen it time and again. But this time your position did something remarkable.
Today we have another new FDA trade! The company is a huge value, especially at today’s prices. Moreover, it has a major catalyst right around the corner, with an FDA decision due just next month.
Over the past few weeks, I’ve reiterated that biotech names will lead the way when the market bounces back. I’ve received a couple emails asking a variety of questions. From the most basic, like how to trade stocks, to why biotech stocks seem so volatile. Today, we’re going to step back and go over the basics so you can prep yourself for the market snapback — with biotech names leading the way.
This first edition of your Pot Timer Pro comes at a strange time in the markets. Everything is rallying today in hopes for a stimulus package from Congress — including the pot market. This sector took a beating in 2019… but with the pandemic and self-quarantining, recent news could prove extremely beneficial to the pot market.
The selloff on the markets is creating strong long term investment opportunities. The crisis will pass, the economy will recover, and business for many companies will return to normal. Investors can get some sweet deals at current prices.
Without a doubt, the market for cannabis stocks remains linked to the broader stock market amid the COVID-19 sell-off. But from a business standpoint, the strongest pot operators are well positioned to survive and thrive in the current environment.
What I’m seeing today, as I sit in my home office with the door closed and headphones on my ears, is huge opportunity for people willing to think clearly and not let fear cloud them. There’s a once-in-a-lifetime opportunity right now to score super-cheap shares in quality names.